You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
Breaking news on Diagnostics business, policy & funding.
Oxsed, a University of Oxford spinout, will continue to focus on prioritizing test access for low- and middle-income countries following the acquisition.
The point-of-care test runs on the VitaPCR instrument and delivers results in 20 minutes, and has been implemented at Charles De Gaulle airport.
The firm's subsidiary BioReference Laboratories performed 3.5 million COVID-19 PCR tests and 300,000 serology tests during the quarter.
Bio-Rad's year-over-year Q3 revenue increase was driven primary by sales of PCR and Droplet Digital PCR products due to the COVID-19 pandemic.
The company reported $53.4 million in total revenues for the quarter and said testing services revenues rose 61 percent year over year.